COMPARISON OF THE CYTO-TOXIC ACTIVITIES OF CHEMOTHERAPEUTIC DRUGS USING A HUMAN BLADDER-CANCER CELL-LINE

被引：13

作者：

HEPBURN, PJ

OLIVER, RTD

RILEY, PA

HILL, BT

MASTERS, JRW

机构：

[1] IMPERIAL CANC RES FUND,CELLULAR CHEMOTHERAPY,LONDON,ENGLAND

[2] ST PAULS HOSP,INST UROL,DEPT ONCOL,LONDON WC2,ENGLAND

[3] UNIV LONDON UNIV COLL,SCH MED,DEPT BIOCHEM PATHOL,LONDON WC1E 6BT,ENGLAND

来源：

UROLOGICAL RESEARCH | 1985年 / 13卷 / 01期

关键词：

D O I：

10.1007/BF00571753

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：27 / 34

页数：8

共 52 条

[11] METHOTREXATE PHARMACOKINETICS [J].

BISCHOFF, KB ;

DEDRICK, RL ;

ZAHARKO, DS ;

LONGSTRETH, JA .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (08) :1128-+

[12]

BRUCE WR, 1966, JNCI-J NATL CANCER I, V37, P233

[13] EARLY CLINICAL-STUDIES WITH CIS-DIAMMINE-1,1-CYCLOBUTANE DICARBOXYLATE PLATINUM-II [J].

CALVERT, AH ;

HARLAND, SJ ;

NEWELL, DR ;

SIDDIK, ZH ;

JONES, AC ;

MCELWAIN, TJ ;

RAJU, S ;

WILTSHAW, E ;

SMITH, IE ;

BAKER, JM ;

PECKHAM, MJ ;

HARRAP, KR .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) :140-147

[14]

CHABNER BA, 1981, CANCER TREAT REP, V65, P51

[15] MITOMYCIN-C - REVIEW [J].

CROOKE, ST ;

BRADNER, WT .

CANCER TREATMENT REVIEWS, 1976, 3 (03) :121-139

[16]

CURT GA, 1983, CANCER RES, V43, P4470

[17]

DICKSON C, 1980, INFECT IMMUN, V28, P649

[18]

DINCALCI M, 1982, CHEMOTHERAPIA, V1, P126

[19] PATTERNS OF CELL SURVIVAL FOLLOWING TREATMENT WITH ANTI-TUMOR AGENTS INVITRO [J].

DREWINKO, B ;

ROPER, PR ;

BARLOGIE, B .

EUROPEAN JOURNAL OF CANCER, 1979, 15 (01) :93-99

[20]

DREWINKO B, 1981, CANCER RES, V41, P2328

← 1 2 3 4 5 6 →